Lianbao Ye

731 total citations
42 papers, 552 citations indexed

About

Lianbao Ye is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lianbao Ye has authored 42 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Lianbao Ye's work include Synthesis and biological activity (6 papers), Liver physiology and pathology (5 papers) and Cancer therapeutics and mechanisms (4 papers). Lianbao Ye is often cited by papers focused on Synthesis and biological activity (6 papers), Liver physiology and pathology (5 papers) and Cancer therapeutics and mechanisms (4 papers). Lianbao Ye collaborates with scholars based in China, United States and Hong Kong. Lianbao Ye's co-authors include Weiqiang Chen, Xiaobao Jin, Lirong Zhang, Jianwen Mao, Ming Li, Ying Liu, Yuanyuan Wang, Xiaohong Chen, Jiajie Zhang and Yuanxin Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Lianbao Ye

40 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianbao Ye China 14 246 130 110 80 53 42 552
Mohamed F. Abdelhameed Egypt 15 189 0.8× 158 1.2× 88 0.8× 72 0.9× 64 1.2× 64 615
Ahmed M. Zaghloul Egypt 13 230 0.9× 89 0.7× 152 1.4× 79 1.0× 46 0.9× 29 471
Mylarappa Ningappa United States 14 126 0.5× 161 1.2× 117 1.1× 100 1.3× 41 0.8× 30 719
Shou-Fang Wu Taiwan 10 216 0.9× 136 1.0× 67 0.6× 27 0.3× 66 1.2× 10 493
P. Sankar India 15 284 1.2× 86 0.7× 93 0.8× 39 0.5× 48 0.9× 43 655
Anagha Damre India 15 265 1.1× 81 0.6× 161 1.5× 57 0.7× 64 1.2× 30 673
Evelyn Winter Brazil 18 351 1.4× 233 1.8× 83 0.8× 52 0.7× 78 1.5× 35 826
María C. Recio Spain 14 323 1.3× 125 1.0× 151 1.4× 78 1.0× 66 1.2× 24 770
Ade Arsianti Indonesia 11 106 0.4× 57 0.4× 91 0.8× 67 0.8× 51 1.0× 59 384
Nikhil Baban Ghate India 18 233 0.9× 90 0.7× 144 1.3× 63 0.8× 48 0.9× 31 736

Countries citing papers authored by Lianbao Ye

Since Specialization
Citations

This map shows the geographic impact of Lianbao Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianbao Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianbao Ye more than expected).

Fields of papers citing papers by Lianbao Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianbao Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianbao Ye. The network helps show where Lianbao Ye may publish in the future.

Co-authorship network of co-authors of Lianbao Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Lianbao Ye. A scholar is included among the top collaborators of Lianbao Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianbao Ye. Lianbao Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Y, Liu, Mengjie Li, Yali Zhang, et al.. (2025). Discovery of novel PDE4 degraders with in vivo anti-inflammatory efficacy. Bioorganic Chemistry. 163. 108675–108675.
2.
Wang, Haojie, Qibing Liu, Lianbao Ye, et al.. (2024). Discovery of Balasubramide Derivative with Tissue‐Specific Anti‐Inflammatory Activity Against Acute Lung Injury by Targeting VDAC1. Advanced Science. 11(48). e2410550–e2410550. 8 indexed citations
3.
Zeng, Ye, Xun Deng, Lisha Shen, et al.. (2024). Advances in plant-derived extracellular vesicles: isolation, composition, and biological functions. Food & Function. 15(23). 11319–11341. 18 indexed citations
4.
Zhong, L., Wenhui Yang, Peishan Li, et al.. (2024). Bioactive matters based on natural product for cardiovascular diseases. SHILAP Revista de lepidopterología. 5(4). 542–565. 5 indexed citations
5.
Yang, Zhaoyong, et al.. (2024). Rhodium-catalyzed C–H α-fluoroalkenylation/annulation of β-ketosulfoxonium ylides with 2,2-difluorovinyl tosylate/oxadiazolones. Chemical Communications. 60(100). 15000–15003. 2 indexed citations
6.
Chen, Gong, et al.. (2023). Design, Synthesis, and Bioactivity Evaluation of Novel Rosin Diterpenoid Derivatives as Potential Anti‐glioma Agents. Chemistry & Biodiversity. 20(8). e202300942–e202300942.
7.
Chen, Jiaxin, et al.. (2023). Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study. International Journal of Molecular Sciences. 24(21). 15549–15549. 4 indexed citations
8.
Li, Jian, et al.. (2022). On-Resin Synthesis of Linear Aryl Thioether Containing Peptides and in-Solution Cyclization via Cysteine SNAr Reaction. Organic Letters. 24(8). 1673–1677. 5 indexed citations
9.
Lin, Leilei, et al.. (2022). Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing TGF-β1 and oxidative stress in PM2.5-exposed hepatocytes. Toxicology and Applied Pharmacology. 437. 115891–115891. 14 indexed citations
10.
Shu, Jing, et al.. (2020). Recognizing and stabilizing miR-21 by chiral ruthenium(II) complexes. BMC Chemistry. 14(1). 26–26. 3 indexed citations
11.
Ye, Lianbao, et al.. (2019). Anti-tumor activities and mechanism study of α-pinene derivative in vivo and in vitro. Cancer Chemotherapy and Pharmacology. 85(2). 367–377. 15 indexed citations
12.
Ye, Lianbao, et al.. (2018). Preparation, Antidermatophyte Activity, and Mechanism of Methylphloroglucinol Derivatives. Frontiers in Microbiology. 9. 2262–2262. 10 indexed citations
13.
Wu, Jie, et al.. (2017). Germacrone derivatives: synthesis, biological activity, molecular docking studies and molecular dynamics simulations. Oncotarget. 8(9). 15149–15158. 18 indexed citations
14.
Ye, Lianbao, et al.. (2015). Design, synthesis and molecular docking analysis of some novel 7-[(quinolin-6-yl)methyl] purines as potential c-Met inhibitors. Medicinal Chemistry Research. 24(8). 3327–3333. 7 indexed citations
15.
Chen, Weiqiang, Ying Liu, Ming Li, et al.. (2015). Anti-tumor effect of α-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest. Journal of Pharmacological Sciences. 127(3). 332–338. 135 indexed citations
16.
Tian, Yuanxin, Yu‐Dong Shen, Xianzuo Zhang, et al.. (2014). Design Some New Type‐I c‐met Inhibitors Based on Molecular Docking and Topomer CoMFA Research. Molecular Informatics. 33(8). 536–543. 10 indexed citations
17.
Ye, Lianbao, Xiaomin Ou, Yuanxin Tian, et al.. (2013). Indazoles as potential c-met inhibitors: Design, synthesis and molecular docking studies. European Journal of Medicinal Chemistry. 65. 112–118. 25 indexed citations
18.
Ye, Lianbao, Yuanxin Tian, Zhonghuang Li, et al.. (2012). Design, synthesis and molecular docking studies of some novel spiro[indoline-3, 4′-piperidine]-2-ones as potential c-Met inhibitors. European Journal of Medicinal Chemistry. 50. 370–375. 32 indexed citations
20.
Ye, Lianbao & Wanjin Zhang. (2007). Synthesis and Biological Activity of 3-(2, 8, 9-Trioxa-aza-1-germatricyclo [3. 3. 3. 0]undecane-1-yl)-hydroxycinnamic Acids. Medicinal Chemistry. 3(5). 466–468. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026